LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: 2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.

    Kennedy, Samantha K F / Goodall, Shannon / Lee, Shing Fung / DeAngelis, Carlo / Jocko, Allison / Charbonneau, Flay / Wang, Katie / Pasetka, Mark / Ko, Yoo-Joung / Wong, Henry C Y / Chan, Adrian Wai / Rajeswaran, Thenugaa / Gojsevic, Milena / Chow, Edward / Gralla, Richard J / Ng, Terry L / Jerzak, Katarzyna J

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

    2024  Volume 32, Issue 5, Page(s) 280

    Abstract: Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with various malignancies ranging from early to end stages. In light of frequent changes to the guidelines for optimal management of CINV, ...

    Abstract Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with various malignancies ranging from early to end stages. In light of frequent changes to the guidelines for optimal management of CINV, we undertook this narrative review to compare the most recent guidelines published by ASCO (2020), NCCN (2023), MASCC/ESMO (2023), and CCO (2019). The processes undertaken by each organization to evaluate existing literature were also described. Although ASCO, NCCN, MASCC/ESMO, and CCO guidelines for the treatment and prevention of CINV share many fundamental similarities, the literature surrounding low and minimal emetic risk regimens is lacking. Current data regarding adherence to these guidelines is poor and warrants further investigation to improve care.
    MeSH term(s) Humans ; Antiemetics/pharmacology ; Quality of Life ; Vomiting/chemically induced ; Vomiting/prevention & control ; Vomiting/drug therapy ; Nausea/chemically induced ; Nausea/prevention & control ; Nausea/drug therapy ; Neoplasms/drug therapy ; Antineoplastic Agents/adverse effects
    Chemical Substances Antiemetics ; Antineoplastic Agents
    Language English
    Publishing date 2024-04-10
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1134446-5
    ISSN 1433-7339 ; 0941-4355
    ISSN (online) 1433-7339
    ISSN 0941-4355
    DOI 10.1007/s00520-024-08462-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3697: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Anticipatory nausea: current landscape and future directions.

    Ahrari, Soha / Chow, Ronald / Goodall, Shannon / DeAngelis, Carlo

    Annals of palliative medicine

    2017  Volume 6, Issue 1, Page(s) 1–2

    MeSH term(s) Antiemetics/therapeutic use ; Antineoplastic Agents/adverse effects ; Benzodiazepines/therapeutic use ; Humans ; Nausea/etiology ; Nausea/prevention & control ; Vomiting, Anticipatory/etiology ; Vomiting, Anticipatory/prevention & control
    Chemical Substances Antiemetics ; Antineoplastic Agents ; Benzodiazepines (12794-10-4)
    Language English
    Publishing date 2017-01
    Publishing country China
    Document type Editorial
    ZDB-ID 2828544-X
    ISSN 2224-5839 ; 2224-5820
    ISSN (online) 2224-5839
    ISSN 2224-5820
    DOI 10.21037/apm.2016.10.01
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study.

    Asthana, Rashi / Zhang, Liying / Wan, Bo Angela / Gallo-Hershberg, Daniela / Giotis, Angie / Pasetka, Mark / van Draanen, Jenna / Goodall, Shannon / Diaz, Patrick L / Drost, Leah / Chow, Edward / De Angelis, Carlo

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

    2019  Volume 28, Issue 2, Page(s) 589–598

    Abstract: Background: Taxane acute pain syndrome (TAPS) is a clinically significant side-effect of taxane chemotherapy, often described as arthralgia and myalgia that occurs 2-3 days after infusion. The aim of this study was to assess pain descriptors used by ... ...

    Abstract Background: Taxane acute pain syndrome (TAPS) is a clinically significant side-effect of taxane chemotherapy, often described as arthralgia and myalgia that occurs 2-3 days after infusion. The aim of this study was to assess pain descriptors used by patients during their experience of TAPS.
    Methods: A clinical prospective cohort study was conducted on breast cancer patients who had not received prior chemotherapy and were asked to complete diaries on three consecutive docetaxel treatment cycles on days 1-7, 14, and 21 (acute phase). Questionnaires to assess pain severity, descriptors of pain, and the interference in activities due to pain were adapted from the Brief Pain Inventory and the McGill Pain Questionnaire. Telephone questionnaire follow-up was done at 1, 3, 6, 9, and 12 months following docetaxel (delayed phase).
    Results: The most commonly used descriptor for acute and chronic pain was "aching" (90-96%). However, in the delayed phase of the study, "burning" (32-50%), "radiating" (39-48%), and "sharp" (40-69%) were used more often. In both acute and chronic pain phases, most patients experienced moderate/severe pain regardless of the location. Pain in cycle 1 was predictive of pain in subsequent taxane cycles (p < 0.0001). Pain in cycle 3 was predictive of chronic pain (p < 0.002).
    Conclusions: The descriptors used by patients experiencing chemotherapy-induced pain (ChIP) may be reflective of the underlying mechanisms. It is suspected that TAPS initiates as an acute inflammatory pain, which over time develops into neuropathic pain, known as chemotherapy-induced peripheral neuropathy (CIPN). However, the subjective pain experience varies from patient to patient.
    MeSH term(s) Acute Pain/chemically induced ; Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/complications ; Breast Neoplasms/drug therapy ; Bridged-Ring Compounds/adverse effects ; Female ; Humans ; Middle Aged ; Prospective Studies ; Taxoids/adverse effects
    Chemical Substances Bridged-Ring Compounds ; Taxoids ; taxane (1605-68-1)
    Language English
    Publishing date 2019-05-17
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1134446-5
    ISSN 1433-7339 ; 0941-4355
    ISSN (online) 1433-7339
    ISSN 0941-4355
    DOI 10.1007/s00520-019-04845-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3697: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top